Skip to main content
Clinical Trials/NCT04949568
NCT04949568Active, not recruitingNot Applicable

Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes: A Pilot Randomized Study

New York University1 site in 1 country40 target enrollmentStarted: August 12, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
40
Locations
1
Primary Endpoint
Stanford Diabetes Self-Efficacy Scale (8- item)

Study Overview

Brief Summary

The objective of the study is to conduct a pilot randomized study to test feasibility and preliminary efficacy of the developed diabetes self-management education program with 40 adult Haitian immigrants.

Detailed Description

This is a two-arm randomized trial. Participants will be randomized to the culturally tailored Diabetes Self-Management Education Program or standard care condition in a 1:1 allocation. All participants will receive standard type 2 diabetes care at the enrolled clinic and remain under their providers' care for the duration of the study. The culturally tailored Diabetes Education Program involves the following: 1) an initial 45-minute face-to-face consultation; and 2) six 2-hour weekly interactive educational sessions in a format to be determined (TBD) by Aim 1 (e.g., in-person, video/telephone conference call).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Masking Description

Both conditions will receive standard care. We will use sequentially numbered opaque sealed envelopes to conceal the allocation determination

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Self-described Haitian immigrant aged 21 and older
  • •Known diagnosis of type 2 diabetes for at least one year
  • •Have lived in the US for at least one year
  • •Have an HbA1c of 7.5%
  • •Willing and able to participate in an individual interview

Exclusion Criteria

  • •Having a diagnosis of type 1 diabetes
  • •Unable to comprehend, consent and or fully participate in the study

Arms & Interventions

Usual Type 2 Diabetes Care

No Intervention

The usual care arm will receive the clinic's standard type 2 diabetes care and remain under their providers' care for the duration of the study.

Diabetes Self-Management Behaviors

Experimental

Self-Management Education Program The culturally tailored Diabetes Self-Management Education Program involves the following: 1) an initial 45-minute face-to-face private consultation collaboratively determining goals; followed by 2) six 2-hour weekly educational interactive sessions in a format TBD by aim 1. We will deliver culturally targeted written materials and presentations in these sessions. Participants will be asked to practice self-management behaviors concurrently and for four additional weeks.

Intervention: Diabetes Self-Management Behaviors (Behavioral)

Outcomes

Primary Outcomes

Stanford Diabetes Self-Efficacy Scale (8- item)

Time Frame: (T0) baseline through (T3) 90 days post-intervention

Change in general self-efficacy 1-10, higher scores indicate improvement)

Wrist-worn actigraphy (ActiGraph) to be worn while awake

Time Frame: (T0) baseline through (T3) 90 days post-intervention

Change in physical activity (Frequent physical activity indicates improvement)

Summary of Diabetes of Self-Care Activities Scale (11- item)

Time Frame: (T0) baseline through (T3) 90 days post-intervention

Change in diabetes self-management behaviors (0-7, higher scores indicate improvement)

Glucose Variability data from continuous glucose monitor (CGM) will be downloaded directly from participants provided (blinded) FreeStyle Libre Pro

Time Frame: (T0) baseline through (T3) 90 days post-intervention

Time in range and glucose variability (More time in range and less glucose variability indicates improvement)

Secondary Outcomes

  • Diabetes Distress Scale (DDS) (17-item), using Numerical Rating Scale: 0-6((T0) baseline through (T3) 90 days post-intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials